QuidelOrtho Corp·4

Feb 3, 7:51 PM ET

Bowman Ronald Lee 4

4 · QuidelOrtho Corp · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

QuidelOrtho (QDEL) CHRO Ronald Bowman Receives 72,302 RSUs

What happened
Ronald Lee Bowman, Chief Human Resources Officer of QuidelOrtho Corporation (QDEL), received two grants of restricted stock units (RSUs) on January 30, 2026 totaling 72,302 RSUs (36,152 and 36,150 RSUs). Both grants were reported as derivative awards (transaction code A) at $0.00 per share—RSUs represent the right to receive one share of common stock upon vesting, not an immediate purchase of shares.

Key details

  • Transaction date: 2026-01-30; Form 4 filed 2026-02-03 (filed within the required two-business-day window).
  • Grant details/pricing: 36,152 RSUs @ $0.00 and 36,150 RSUs @ $0.00 (derivative awards).
  • Vesting (from filing footnotes):
    • The 36,152 RSUs: 12,050 vest on 1/30/2027; the remaining 24,102 vest in equal installments on 1/30/2028 and 1/30/2029.
    • The 36,150 RSUs: vest in equal installments on 1/30/2027, 1/30/2028 and 1/30/2029.
  • Shares owned following the transaction: not specified in the filing.
  • No 10b5-1 plan, tax withholding, or immediate sale noted in the filing.

Context
RSU grants are a form of equity compensation and become actual shares only when they vest. Such awards are common for senior executives and reflect compensation decisions by the company rather than an immediate bullish or bearish trading signal; purchases by insiders typically carry more direct sentiment information for investors.

Insider Transaction Report

Form 4
Period: 2026-01-30
Bowman Ronald Lee
Chief Human Resources Officer
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-01-30+36,15236,152 total
    Common Stock (36,152 underlying)
  • Award

    Non-Qualified Stock Options

    [F3]
    2026-01-30+36,15036,150 total
    Exercise: $27.17Exp: 2036-01-30Common Stock (36,150 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
  • [F2]12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.
  • [F3]36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.
Signature
/s/ Jennifer Ahn, attorney-in-fact for Ronald Lee Bowman|2026-02-03

Documents

1 file
  • 4
    wk-form4_1770166296.xmlPrimary

    FORM 4